Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001297228 | SCV001486235 | likely benign | Singleton-Merten syndrome 1; Aicardi-Goutieres syndrome 7 | 2023-12-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002538485 | SCV003717988 | uncertain significance | Inborn genetic diseases | 2022-07-21 | criteria provided, single submitter | clinical testing | The c.1134A>T (p.Q378H) alteration is located in exon 6 (coding exon 6) of the IFIH1 gene. This alteration results from a A to T substitution at nucleotide position 1134, causing the glutamine (Q) at amino acid position 378 to be replaced by a histidine (H). The p.Q378H alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |